Found 17 articles for: "Steroid"
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | Original Article | 228 | Copyright © March 2026
Background: Chronic hand eczema (CHE) is a common, heterogeneous inflammatory skin disease associated with substantial symptom burden, impaired hand function, reduced quality of ...
Read MoreAdvanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel
March 2026 | Volume 25 | Issue 3 | Original Article | 221 | Copyright © March 2026
Background: Advanced topical nonsteroidal therapies are expanding options for atopic dermatitis (AD) by providing targeted anti-inflammatory control without many limitations of l...
Read MoreRuxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Original Article | 1036 | Copyright © October 2025
Atopic dermatitis (AD), a chronic inflammatory skin disease, is typically treated with topical corticosteroids in patients with mild to moderate disease, creating an ongoing need for nonsteroidal...
Read MoreUnderstanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1057 | Copyright © October 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
Precision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
June 2025 | Volume 24 | Issue 6 | Case Reports | 634 | Copyright © June 2025
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used...
Read MoreTopical Corticosteroid Potencies: Reimagining A New Universal Classification System
May 2025 | Volume 24 | Issue 5 | Original Article | 458 | Copyright © May 2025
Topical corticosteroids (TCS) are an effective and generally tolerable class of medications frequently used for a wide variety of dermatologic conditions. There are many currently available TCS, ...
Read MoreOff-Label Management Strategies for Generalized Granuloma Annulare: What's New?
April 2025 | Volume 24 | Issue 4 | Features | 425 | Copyright © April 2025
Comparative Efficacy of Intralesional Steroid Injections vs Cryotherapy for the Treatment of Alopecia Areata
March 2025 | Volume 24 | Issue 3 | Original Article | 294 | Copyright © March 2025
Introduction: The precise etiology of alopecia areata (AA) remains unclear. Various treatments, including corticosteroids, minoxidil, immunotherapy, and phototherapy, have shown ...
Read MoreTopical Steroids Sold as Fade Creams in Beauty Supply Stores: A Danger for Cosmetic Consumers
September 2024 | Volume 23 | Issue 9 | Original Article | 709 | Copyright © September 2024
Topical corticosteroids are used extensively in dermatology. Class 1 high potency topical steroids (HPTS) can result in unwanted side effects such as skin hypopigmentation, atrophy, and acneiform...
Read MoreSteroids Used to Treat Acne Vulgaris: A Review of Efficacy, Safety, and Clinical Considerations
June 2024 | Volume 23 | Issue 6 | Original Article | 404 | Copyright © June 2024
Acne vulgaris is prevalent among adolescents and adults worldwide and can significantly impact patients' quality of life. Steroidal molecules, including oral and intralesional corticosteroids, co...
Read MoreComparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus
March 2024 | Volume 23 | Issue 3 | Editorials | e97 | Copyright © March 2024
Background: Previous clinical trials have demonstrated that rituximab therapy combined with conventional steroid-sparing therapy (SST) has increased rates of disease control for ...
Read MoreSarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Evaluating Quality and Reliability of Most-Viewed YouTube Videos on Topical Steroid Withdrawal
November 2023 | Volume 22 | Issue 11 | Features | 1128 | Copyright © November 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 736 | Copyright © August 2023
This article aims to provide consensus statements on the use of corticosteroid-containing topical medications for the management of psoriasis. This Psoriasis Expert Group (PEG) includes dermatolo...
Read MoreBreaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene
March 2023 | Volume 22 | Issue 3 | Original Article | 247 | Copyright © March 2023
Topical therapies are commonly used to treat psoriasis, either as monotherapy for milder disease or as adjuncts to systemic and biologic drugs. Topical steroids and tazarotene are both options fo...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
